Schedule of enrolment, intervention and outcome measures
Enrolment and allocation | Treatment period | Follow-up period | |||||
Screening | Allocation | ||||||
Timepoint | Week −1 | Week 0 | Week 1 | Week 2–5 | Week 6 | Week 12 | Week 26 |
Enrolment | |||||||
Inclusion/exclusion criteria | × | ||||||
Informed consent | × | ||||||
Medical history | × | ||||||
Physical examination | × | ||||||
Baseline characteristics | × | ||||||
Allocation | × | ||||||
Intervention | |||||||
Tuina | × | × | × | ||||
CSE | × | × | × | ||||
Outcomes | |||||||
NRS | × | × | × | × | |||
Credibility | × | ||||||
RMDQ | × | × | × | × | |||
EQ-5D | × | × | × | × | |||
PCS | × | × | × | × | |||
TSK | × | × | × | × | |||
DASS | × | × | × | × | |||
GBRS | × | × | × | ||||
Satisfaction | × | × | × | ||||
Biomechanical outcomes | × | × | |||||
Medication use | × | × | × | × | |||
Healthcare utilisation | × | × | × | × | |||
Absenteeism | × | × | × | × | |||
Adverse events | × | ||||||
Treatment adherence | × |
CSE, core stability exercise; DASS, Depression Anxiety Stress Scale; EQ-5D, EuroQoL-5 dimensions questionnaire; GBRS, Global Back Recovery Scale; NRS, Numeric Rating Scale; PCS, Pain Catastrophizing Scale; RMDQ, Roland-Morris Disability Questionnaire; TSK, Tampa Scale of Kinesiophobia.